These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir. Suryawanshi P; Bagul R; Shete A; Thakar M Front Immunol; 2021; 12():663919. PubMed ID: 33995393 [TBL] [Abstract][Full Text] [Related]
5. Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. Laird GM; Bullen CK; Rosenbloom DI; Martin AR; Hill AL; Durand CM; Siliciano JD; Siliciano RF J Clin Invest; 2015 May; 125(5):1901-12. PubMed ID: 25822022 [TBL] [Abstract][Full Text] [Related]
6. The role of latency reversal agents in the cure of HIV: A review of current data. Bashiri K; Rezaei N; Nasi M; Cossarizza A Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743 [TBL] [Abstract][Full Text] [Related]
7. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4 Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S J Virol; 2018 May; 92(9):. PubMed ID: 29444937 [TBL] [Abstract][Full Text] [Related]
8. Determinants of the efficacy of HIV latency-reversing agents and implications for drug and treatment design. Ke R; Conway JM; Margolis DM; Perelson AS JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333308 [TBL] [Abstract][Full Text] [Related]
9. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients. Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416 [TBL] [Abstract][Full Text] [Related]
10. The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency. de Armas LR; Gavegnano C; Pallikkuth S; Rinaldi S; Pan L; Battivelli E; Verdin E; Younis RT; Pahwa R; Williams SL; Schinazi RF; Pahwa S Front Immunol; 2021; 12():720697. PubMed ID: 34531866 [TBL] [Abstract][Full Text] [Related]
11. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection. Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407 [TBL] [Abstract][Full Text] [Related]
12. Identification of celastrol as a novel HIV-1 latency reversal agent by an image-based screen. Liu H; Hu PW; Dubrulle J; Stossi F; Nikolai BC; Mancini MA; Rice AP PLoS One; 2021; 16(4):e0244771. PubMed ID: 33914760 [TBL] [Abstract][Full Text] [Related]
13. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response. Peng W; Hong Z; Chen X; Gao H; Dai Z; Zhao J; Liu W; Li D; Deng K Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094131 [TBL] [Abstract][Full Text] [Related]
14. New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Bullen CK; Laird GM; Durand CM; Siliciano JD; Siliciano RF Nat Med; 2014 Apr; 20(4):425-9. PubMed ID: 24658076 [TBL] [Abstract][Full Text] [Related]
15. Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents. Gupta V; Dixit NM PLoS Comput Biol; 2018 Feb; 14(2):e1006004. PubMed ID: 29451894 [TBL] [Abstract][Full Text] [Related]
16. Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. Xing S; Bullen CK; Shroff NS; Shan L; Yang HC; Manucci JL; Bhat S; Zhang H; Margolick JB; Quinn TC; Margolis DM; Siliciano JD; Siliciano RF J Virol; 2011 Jun; 85(12):6060-4. PubMed ID: 21471244 [TBL] [Abstract][Full Text] [Related]
17. Bryostatin-1 Decreases HIV-1 Infection and Viral Production in Human Primary Macrophages. Hany L; Turmel MO; Barat C; Ouellet M; Tremblay MJ J Virol; 2022 Feb; 96(4):e0195321. PubMed ID: 34878918 [TBL] [Abstract][Full Text] [Related]